Skip to main content
. 2016 Jun 17;7(34):55721–55731. doi: 10.18632/oncotarget.10124

Table 3. Treatment-related toxicities.

Adverse events Grade 1/2 Grade3/4
No. % No. %
Hematologic
 Leukopenia 9 37.50 14 58.33
 Neutropenia 5 20.83 18 75.00
 Anemia 14 58.33 9 37.50
 Thrombocytopenia 6 25.00 11 45.83
Nonhematologic
 Nausea/vomiting 14 58.33 7 29.17
 ALT/AST elevation 14 58.33 1 4.17
 Increased BUN 2 8.33 0 --
 Heighten of hemodiastase 0
 Increased urinary amylase 0
Coagulation disorders
 APTT elongation 12 (50.00%)
 Hypofibrinogenemia 14 (58.33%)